An Innovative Biotech with a Robust R&D Engine Driving the Development of First-in-Class and Best-in-Class Ophthalmic Drugs. Cloudbreak Pharma leads ophthalmic drug development through CBT-001 and CBT-004, targeting unmet needs in pterygium and other serious eye diseases.